glabridin has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jen, SH; Wei, MP; Yin, AC | 1 |
Hou, MF; Hsu, YL; Hung, CH; Jong, YJ; Kuo, PL; Lee, JN; Liang, HL; Tsai, EM; Wu, LY | 1 |
2 other study(ies) available for glabridin and Adenocarcinoma
Article | Year |
---|---|
The Combinatory Effects of Glabridin and Tamoxifen on Ishikawa and MCF-7 Cell Lines.
Topics: Adenocarcinoma; Breast Neoplasms; Cell Line, Tumor; Drug Therapy, Combination; Endometrial Neoplasms; Estrogens; Female; Humans; Isoflavones; Phenols; Phytoestrogens; Selective Estrogen Receptor Modulators; Tamoxifen | 2015 |
Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway.
Topics: Adenocarcinoma; Angiogenesis Inhibitors; Animals; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Line, Tumor; Cell Migration Assays; Cell Movement; Cells, Cultured; Endothelium, Vascular; Female; Focal Adhesion Protein-Tyrosine Kinases; Glycyrrhiza; Humans; Isoflavones; Mice; Mice, Nude; Phenols; Plant Roots; Random Allocation; rhoA GTP-Binding Protein; Signal Transduction; Xenograft Model Antitumor Assays | 2011 |